Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
inDEX: Dexmedetomidine for NIV Intolerance in Critical Care
NCT06259565Phase 3Recruiting
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Jul 2025
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in acute respiratory failure (ARF), sponsored by St. Joseph's Healthcare Hamilton. Started Jul 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
acute respiratory failure (ARF)
Beyond the preview
Go deeper on NCT06259565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06259565.